Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 87,400 | 64,100 | 55,209 | 81,847 | 92,477 |
| Marketable Securities | 68,000 | 80,700 | 79,224 | 105,406 | 89,807 |
| Receivables | 85,000 | 87,700 | 95,187 | 86,553 | 86,961 |
| Inventories | 34,300 | 25,100 | 29,359 | 20,173 | 24,775 |
| Income taxes - deferred | 13,500 | 13,500 | 13,460 | 12,813 | 13,229 |
| TOTAL | $307,300 | $283,600 | $282,424 | $320,088 | $335,366 |
| Non-Current Assets | |||||
| PPE Net | 64,900 | 67,200 | 69,099 | 46,458 | 43,424 |
| Investments And Advances | 43,100 | 40,600 | 41,200 | 42,300 | 54,073 |
| Intangibles | 366,700 | 369,800 | 380,919 | 368,008 | 371,143 |
| Other Non-Current Assets | 5,000 | 5,000 | 5,407 | 5,000 | 5,000 |
| TOTAL | $479,700 | $482,600 | $496,625 | $461,766 | $473,640 |
| Total Assets | $787,000 | $766,200 | $779,049 | $781,854 | $809,006 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,800 | 21,100 | 17,955 | 16,833 | 25,728 |
| Accrued Expenses | 41,800 | 46,100 | 47,879 | 41,180 | 40,654 |
| TOTAL | $59,000 | $68,700 | $67,173 | $59,837 | $67,725 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,400 | 1,500 | 1,339 | 1,824 | 1,343 |
| Other Non-Current Liabilities | 34,300 | 35,200 | 32,531 | 25,326 | 24,514 |
| TOTAL | $40,900 | $35,400 | $42,978 | $27,776 | $29,131 |
| Total Liabilities | $99,900 | $104,100 | $110,151 | $87,613 | $96,856 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 69,772 | N/A | 69,451 | 71,119 | 72,985 |
| Common Shares | 700 | 700 | 700 | 719 | 729 |
| Retained earnings | -78,800 | -77,000 | -62,282 | -36,975 | -17,449 |
| Other shareholders' equity | -7,100 | -7,000 | -7,560 | -4,182 | -2,368 |
| TOTAL | $687,100 | $662,100 | $668,898 | $694,241 | $712,150 |
| Total Liabilities And Equity | $787,000 | $766,200 | $779,049 | $781,854 | $809,006 |